Float Short %

0.25

Margin Of Safety %

Put/Call OI Ratio

0.71

EPS Next Q Diff

-0.9

EPS Last/This Y

EPS This/Next Y

5.99

Price

78.72

Target Price

120.09

Analyst Recom

1.77

Performance Q

-33.33

Relative Volume

2.97

Beta

0.45

Ticker: NVO

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2024-12-19	NVO	103.46	0.66	0.50	604783
2024-12-20	NVO	85.01	0.65	0.51	638382
2024-12-23	NVO	88.76	0.54	0.88	438245
2024-12-24	NVO	87.44	0.54	0.47	453777
2024-12-26	NVO	87.68	0.53	3.68	459292
2024-12-27	NVO	87.37	0.53	1.10	463063
2024-12-30	NVO	85.74	0.65	0.31	387037
2024-12-31	NVO	86.02	0.62	0.54	388381
2025-01-02	NVO	87.54	0.62	1.72	394365
2025-01-03	NVO	87.65	0.63	1.47	398563
2025-01-06	NVO	85.04	0.75	1.38	364482
2025-01-07	NVO	83.34	0.82	1.46	388188
2025-01-08	NVO	85.63	0.83	0.19	396550
2025-01-09	NVO	85.64	0.83	0.30	396550
2025-01-10	NVO	86.28	0.78	1.20	407688
2025-01-13	NVO	84.6	0.80	1.37	397615
2025-01-14	NVO	81.2	0.79	1.01	400642
2025-01-15	NVO	82.91	0.72	0.94	405193
2025-01-16	NVO	83.06	0.72	7.22	408692
2025-01-17	NVO	78.73	0.71	1.12	417479
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2024-12-19	NVO	103.46	30.4	3823.4	22.85
2024-12-20	NVO	84.99	30.4	816.2	22.85
2024-12-23	NVO	88.71	30.4	1590.9	22.85
2024-12-24	NVO	87.37	30.4	4656.0	22.85
2024-12-26	NVO	87.65	30.4	4725.2	22.85
2024-12-27	NVO	87.35	30.4	4651.1	22.85
2024-12-30	NVO	85.74	30.4	4645.3	22.85
2024-12-31	NVO	86.01	30.4	4583.2	22.85
2025-01-02	NVO	87.54	30.4	4965.4	22.85
2025-01-03	NVO	87.68	30.4	4387.7	22.85
2025-01-06	NVO	85.01	30.4	4685.7	22.85
2025-01-07	NVO	83.33	30.4	4265.4	22.85
2025-01-08	NVO	85.64	30.4	6076.9	22.85
2025-01-09	NVO	85.64	30.4	5465.8	22.85
2025-01-10	NVO	86.28	30.4	5630.6	22.85
2025-01-13	NVO	84.61	30.4	4759.6	22.85
2025-01-14	NVO	81.19	30.4	4824.1	22.85
2025-01-15	NVO	82.92	30.4	6048.2	22.85
2025-01-16	NVO	83.10	30.4	5621.2	22.85
2025-01-17	NVO	78.72	34.6	4566.0	22.85
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2024-12-19	NVO	0.00	-0.37	0.17
2024-12-20	NVO	0.00	-0.37	0.17
2024-12-23	NVO	0.00	-0.93	0.17
2024-12-24	NVO	0.00	-0.93	0.17
2024-12-26	NVO	0.00	-0.93	0.14
2024-12-27	NVO	0.00	-0.93	0.14
2024-12-30	NVO	0.00	-1.51	0.14
2024-12-31	NVO	0.00	-1.51	0.14
2025-01-02	NVO	0.00	-1.51	0.14
2025-01-03	NVO	0.00	-1.51	0.14
2025-01-06	NVO	0.00	-0.98	0.14
2025-01-07	NVO	0.00	-0.98	0.14
2025-01-08	NVO	0.00	-0.98	0.14
2025-01-09	NVO	0.00	-0.98	0.14
2025-01-10	NVO	0.00	-0.98	0.14
2025-01-13	NVO	0.00	-0.58	0.25
2025-01-14	NVO	0.00	-0.58	0.25
2025-01-15	NVO	0.00	-0.58	0.25
2025-01-16	NVO	0.00	-0.58	0.25
2025-01-17	NVO	0.00	-0.58	0.25
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.9

Avg. EPS Est. Current Quarter

6.4

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.58

Beta

0.45

Average Sales Estimate Current Quarter

81109

Average Sales Estimate Next Quarter

79537

Fair Value

105.28

Quality Score

Growth Score

100

Sentiment Score

Actual DrawDown %

46.9

Max Drawdown 5-Year %

-44.7

Target Price

120.09

P/E

25.52

Forward P/E

20.33

PEG

1.06

P/S

6.68

P/B

14.56

P/Free Cash Flow

23.18

EPS

3.08

Average EPS Est. Cur. Y

22.85

EPS Next Y. (Est.)

28.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

35.03

Relative Volume

2.97

Return on Equity vs Sector %

59.5

Return on Equity vs Industry %

51.9

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.13

EBIT Estimation

4566

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 71880

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases; and with Valo Health, Inc. to discover and develop novel treatments for obesity, type 2 diabetes, and cardiovascular disease. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y